PLIMGOA Trademark Information

Trademark by Glaxo Group Limited

Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncolog...

Classification Information

Use in Commerce Trademark - Applicant has provided proof of use of this mark in commerce to USPTO.

Primary Class: Class Details:
Class (005)
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
First Use Anywhere:: Not provided
First Use In Commerce: Not provided
General Information
Word mark: PLIMGOA
Status/Status Date:
REGISTERED
12/25/2018
Serial Number: 87904444
Filing Date: 5/2/2018
Registration Number: 5637303
Registration Date: 12/25/2018
Goods and Services: Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines
Mark Description: NOT AVAILABLE
Type Of Mark: TradeMark
Published For Opposition Date: 10/9/2018
Last Applicant/Owner:
Glaxo Group Limited
Brentford, Middlesex TW89GS
Mark Drawing Code: Standard Character Mark
Design Search:
(NO DATA)
Register Type: Principal
Disclaimer: (NOT AVAILABLE)
Correspondent:
GSK
5 MOORE DRIVE
LBP, 5.5A
RESEARCH TRIANGLE PARK, NC 27709-3398
Current Status:
REGISTERED
12/25/2018
Correspondent Search:
MERILEE J. AREVALO is a correspondent of PLIMGOA trademark.
Current Overall Rating:
RatingRatingRatingRatingRating

(0 review)

As seen on